Literature DB >> 21494034

Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment.

Daniel Varon1, David A Loewenstein, Elizabeth Potter, Maria T Greig, Joscelyn Agron, Qian Shen, Weizhao Zhao, Maria Celeste Ramirez, Isael Santos, Warren Barker, Huntington Potter, Ranjan Duara.   

Abstract

BACKGROUND: In Alzheimer's disease, neurodegenerative atrophy progresses from the entorhinal cortex (ERC) to the hippocampus (HP), limbic system and neocortex. The significance of very mild atrophy of the ERC and HP on MRI scans among elderly subjects is unknown.
METHODS: A validated visual rating system on coronal MRI scans was used to identify no atrophy of the HP or ERC (HP(0); ERC(0)), or minimal atrophy of the HP or ERC (HP(ma); ERC(ma)), among 414 participants. Subjects fell into the following groups: (1) ERC(0)/HP(0), (2) ERC(ma)/HP(0), (3) ERC(0)/HP(ma), and (4) ERC(ma)/HP(ma). HP volume was independently measured using volumetric methods.
RESULTS: In comparison to ERC(0)/HP(0) subjects, those with ERC(0)/HP(ma) had impairment on 1 memory test, ERC(ma)/HP(0) subjects had impairment on 2 memory tests and the Mini Mental State Examination (MMSE), while ERC(ma)/HP(ma) subjects had impairment on 3 memory tests, the MMSE and Clinical Dementia Rating. Progression rates of cognitive and functional impairment were significantly greater among subjects with ERC(ma).
CONCLUSION: Minimal atrophy of the ERC results in greater impairment than minimal atrophy of the HP, and the combination is additive when measured by cognitive and functional tests. Rates of progression to greater impairment were higher among ERC(ma) subjects.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494034      PMCID: PMC3085034          DOI: 10.1159/000324711

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  35 in total

1.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

Authors:  R J Killiany; B T Hyman; T Gomez-Isla; M B Moss; R Kikinis; F Jolesz; R Tanzi; K Jones; M S Albert
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Authors:  M Riemenschneider; N Lautenschlager; S Wagenpfeil; J Diehl; A Drzezga; A Kurz
Journal:  Arch Neurol       Date:  2002-11

6.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Authors:  C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

7.  Entorhinal cortex volume in older adults: reliability and validity considerations for three published measurement protocols.

Authors:  C C Price; M F Wood; C M Leonard; S Towler; J Ward; H Montijo; I Kellison; D Bowers; T Monk; J C Newcomer; I Schmalfuss
Journal:  J Int Neuropsychol Soc       Date:  2010-09       Impact factor: 2.892

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

View more
  11 in total

1.  Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia.

Authors:  Shanna L Burke; Miriam J Rodriguez; Warren Barker; Maria T Greig-Custo; Monica Rosselli; David A Loewenstein; Ranjan Duara
Journal:  J Int Neuropsychol Soc       Date:  2017-09-18       Impact factor: 2.892

Review 2.  Mapping Neurodegenerative Disease Onset and Progression.

Authors:  William W Seeley
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 3.  The entorhinal cortex and neurotrophin signaling in Alzheimer's disease and other disorders.

Authors:  Helen E Scharfman; Moses V Chao
Journal:  Cogn Neurosci       Date:  2013-08-25       Impact factor: 3.065

4.  Microglia in the normally aged hippocampus.

Authors:  Jung Hoon Choi; Moo-Ho Won
Journal:  Lab Anim Res       Date:  2011-09-30

5.  Two Alzheimer's disease risk genes increase entorhinal cortex volume in young adults.

Authors:  Amanda Marie DiBattista; Benson W Stevens; G William Rebeck; Adam E Green
Journal:  Front Hum Neurosci       Date:  2014-10-06       Impact factor: 3.169

6.  Manual Planimetry of the Medial Temporal Lobe Versus Automated Volumetry of the Hippocampus in the Diagnosis of Alzheimer's Disease.

Authors:  Manuel Menéndez González; Esther Suárez-Sanmartin; Ciara García; Pablo Martínez-Camblor; Eric Westman; Andy Simmons
Journal:  Cureus       Date:  2016-03-26

7.  Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults.

Authors:  Nicole M Armstrong; Chiung-Wei Huang; Owen A Williams; Murat Bilgel; Yang An; Jimit Doshi; Guray Erus; Christos Davatzikos; Dean F Wong; Luigi Ferrucci; Susan M Resnick
Journal:  Neuroimage Clin       Date:  2019-03-11       Impact factor: 4.881

8.  Comparison of medial temporal measures between Binswanger's disease and Alzheimer's disease.

Authors:  Xuntao Yin; Chen Liu; Li Gui; Lu Zhao; Jiuquan Zhang; Luqing Wei; Bing Xie; Daiquan Zhou; Chuanming Li; Jian Wang
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

9.  Reference Intervals for Plasma Amyloid β in Korean Adults Without Cognitive Impairment.

Authors:  Min Young Kim; Kyu Nam Kim; Hye Min Cho; Duck Joo Lee; Doo Yeoun Cho
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

10.  Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometry.

Authors:  Daniel J Tward; Chelsea S Sicat; Timothy Brown; Arnold Bakker; Michela Gallagher; Marilyn Albert; Michael Miller
Journal:  Alzheimers Dement (Amst)       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.